Table II.
Higher serum marker values are significantly associated with presence of Stage IV disease, intermediate-high or high IPI score and FLIPI score >3.
| Covariate | STAGE I, II, III |
STAGE IV |
p-value | IPI=L | IPI=LI | IPI=IH | p-value | FLIPI=0,1 | FLIPI=2 | FLIP≥3 | p-value | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| sCD44 | low | 21(48.8%) | 22(51.2%) | .0008 | 34(77.3%) | 7(15.9%) | 3(6.8%) | .0265 | 36(81.8%) | 5(11.4%) | 3(6.8%) | <.0001 |
| high | 8(16.3%) | 41(83.7%) | 25(51%) | 19(38.8%) | 5(10.2%) | 17(34.7%) | 25(51%) | 7(14.3%) | ||||
| sICAM-1 | low | 20(46.5%) | 23(53.5%) | .0037 | 34(77.3%) | 10(22.7%) | 0(0%) | .0035 | 35(79.5%) | 8(18.2%) | 1(2.3%) | .0001 |
| high | 9(18.4%) | 40(81.6%) | 25(51%) | 16(32.7%) | 8(16.3%) | 18(36.7%) | 22(44.9%) | 9(18.4%) | ||||
| sVCAM-1 | low | 24(53.3%) | 21(46.7%) | <.0001 | 38(82.6%) | 8(17.4%) | 0(0%) | .0001 | 38(82.6%) | 7(15.2%) | 1(2.2%) | <.0001 |
| high | 5(10.6%) | 42(89.4%) | 21(44.7%) | 18(38.3%) | 8(17%) | 15(31.9%) | 23(48.9%) | 9(19.1%) | ||||